3 US Penny Stocks With Market Caps Under $400M To Consider

As the United States market experiences a late-year slump, with major indices like the Dow Jones and S&P 500 turning lower, investors are increasingly looking for opportunities outside of large-cap stocks. Penny stocks, despite their somewhat outdated name, remain an area of interest for those seeking smaller or newer companies that may offer unique value propositions. This article will explore three penny stocks that stand out due to their financial strength and potential for long-term growth in today's market landscape.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
BAB (OTCPK:BABB)	$0.8301	$6.25M	★★★★★★
Inter & Co (NasdaqGS:INTR)	$4.19	$1.87B	★★★★☆☆
QuantaSing Group (NasdaqGM:QSG)	$3.08	$104.78M	★★★★★★
ZTEST Electronics (OTCPK:ZTST.F)	$0.285	$9.2M	★★★★★★
Tantech Holdings (NasdaqCM:TANH)	$0.23	$1.59M	★★★★★★
Imperial Petroleum (NasdaqCM:IMPP)	$3.07	$87.96M	★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U)	$4.50	$67.38M	★★★★★★
BTCS (NasdaqCM:BTCS)	$2.50	$44.07M	★★★★★★
Smith Micro Software (NasdaqCM:SMSI)	$1.39	$25.72M	★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)	$1.08	$96.23M	★★★★★☆

Click here to see the full list of 737 stocks from our US Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Connect Biopharma Holdings (NasdaqGM:CNTB)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company focused on developing therapies for T cell-driven inflammatory diseases, with a market cap of $62.99 million.

Operations: Connect Biopharma Holdings Limited does not report any revenue segments.

Market Cap: $62.99M

Connect Biopharma Holdings Limited, with a market cap of US$62.99 million, is a pre-revenue clinical-stage biopharmaceutical firm focused on T cell-driven inflammatory diseases. Despite being unprofitable, it has reduced losses by 21.1% annually over the past five years and maintains stable short-term assets of US$115.9 million against liabilities. The company is debt-free and its stock trades at good value relative to peers. However, recent leadership changes and high volatility remain concerns for investors in penny stocks like Connect Biopharma Holdings Limited as they navigate this speculative investment landscape.

• Take a closer look at Connect Biopharma Holdings' potential here in our financial health report.
• Gain insights into Connect Biopharma Holdings' outlook and expected performance with our report on the company's earnings estimates.

Xunlei (NasdaqGS:XNET)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Xunlei Limited, along with its subsidiaries, operates an internet platform for digital media content in the People's Republic of China and has a market cap of approximately $130.59 million.

Operations: The company generates revenue primarily from the operation of its online media platform, amounting to $359.61 million.

Market Cap: $130.59M

Xunlei Limited, with a market cap of US$130.59 million, operates an internet platform in China and reported third-quarter revenue of US$79.84 million, slightly down from the previous year. Despite this decline, net income improved to US$4.6 million, indicating profitability growth over the past year at 139.4%, significantly outpacing the industry average. The company maintains strong financial health with short-term assets covering both short- and long-term liabilities and has more cash than debt. Recent board changes include appointing He Huang as an independent director following Ya Li's resignation, reflecting ongoing governance adjustments amidst stable earnings performance.

• Get an in-depth perspective on Xunlei's performance by reading our balance sheet health report here.
• Review our historical performance report to gain insights into Xunlei's track record.

Oil States International (NYSE:OIS)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Oil States International, Inc. offers engineered capital equipment and products for the energy, industrial, and military sectors globally with a market cap of approximately $302.93 million.

Operations: The company generates revenue from three main segments: Downhole Technologies ($74.55 million), Offshore/Manufactured Products ($476.69 million), and Completion and Production Services ($185.02 million).

Market Cap: $302.93M

Oil States International, Inc., with a market cap of US$302.93 million, operates in the energy sector and recently reported third-quarter revenue of US$174.35 million, down from the previous year, resulting in a net loss of US$14.35 million. Despite current unprofitability, the company has reduced losses over five years by 65.5% annually and maintains a solid financial position with short-term assets exceeding liabilities and a satisfactory net debt to equity ratio of 11.6%. The company announced a share repurchase program worth up to US$50 million through October 2026, reflecting confidence in its long-term value proposition despite recent impairments totaling US$10.79 million.

• Click here and access our complete financial health analysis report to understand the dynamics of Oil States International.
• Explore Oil States International's analyst forecasts in our growth report.

Seize The Opportunity

• Reveal the 737 hidden gems among our US Penny Stocks screener with a single click here.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com